Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancer. Ambrosini M, Rousseau B, Manca P, Artz O, et al. Ann Oncol 2024 May 3:S0923-7534(24)00104-2. doi: 10.1016/j.annonc.2024.

Read + Share

Amedeo Smart

Independent Medical Education

Ambrosini M, Rousseau B, Manca P, Artz O, et al. Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancer. Ann Oncol 2024 May 3:S0923-7534(24)00104-2. doi: 10.1016/j.annonc.2024.
PMID: 38777726